Mylan Investors

As one of the world’s leading generics and specialty pharmaceutical companies, our products reach approximately 165 countries and territories. Our leading position in key global markets is based on a broad product portfolio, robust pipeline, more than 30,000 workforce, wide range of dosage forms and delivery systems, large manufacturing capacity and dedication to quality and service.

2016.02.10, 4:00 PM ET

MYL Last Trade

50.54

Change

0

Daily High

0

Daily Low

0

Daily Volume

63,240




Mylan will provide shareholders, upon request, a hard copy of its latest 10-K free of charge.


Get the latest from Mylan
Sign up for email alerts




Upcoming Events

Past Events

Event Default

Fourth Quarter and Full Year 2015 Financial Results

Feb. 10, 2016 | 4:30 PM EST

Download Presentation
Event Default

J.P. Morgan 34th Annual Healthcare Conference

San Francisco | CA
Jan 12, 2016 | 5:30 PM EST

Listen to Webcast

Event Default

Goldman Sachs Healthcare CEOs Unscripted: A View From the Top Conference

Boston | MA
Jan 5, 2016 | 08:00 AM EST

Listen to Webcast

Leadership

Meet our passionate global leaders.